Correlation Between Vivani Medical and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Vivani Medical and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivani Medical and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vivani Medical and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Vivani Medical and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivani Medical with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivani Medical and Mineralys Therapeutics,.
Diversification Opportunities for Vivani Medical and Mineralys Therapeutics,
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Vivani and Mineralys is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Vivani Medical and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Vivani Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivani Medical are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Vivani Medical i.e., Vivani Medical and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Vivani Medical and Mineralys Therapeutics,
Given the investment horizon of 90 days Vivani Medical is expected to generate 0.83 times more return on investment than Mineralys Therapeutics,. However, Vivani Medical is 1.2 times less risky than Mineralys Therapeutics,. It trades about 0.07 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about -0.04 per unit of risk. If you would invest 125.00 in Vivani Medical on September 13, 2024 and sell it today you would earn a total of 5.50 from holding Vivani Medical or generate 4.4% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vivani Medical vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Vivani Medical |
| Mineralys Therapeutics, |
Vivani Medical and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vivani Medical and Mineralys Therapeutics,
The main advantage of trading using opposite Vivani Medical and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivani Medical position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Vivani Medical vs. PepGen | Vivani Medical vs. Tyra Biosciences | Vivani Medical vs. Entrada Therapeutics | Vivani Medical vs. Pharvaris BV |
| Mineralys Therapeutics, vs. Puma Biotechnology | Mineralys Therapeutics, vs. Iovance Biotherapeutics | Mineralys Therapeutics, vs. Sarepta Therapeutics | Mineralys Therapeutics, vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |